Biotechnology is no longer a field for insiders only. It has become the lens through which we read the markets, the capital flows and the industrial choices of the years ahead. Human+ Healthcare Dialogues #3, LIFE REDESIGNED brings this story to an audience that is only now approaching biotech: students, investors and professionals coming from the digital and robotics world. On stage, institutional voices will alternate with researchers who turned their own discoveries into companies, entrepreneurs entering the clinical stage, and those who look at the sector from the standpoint of international capital. A conversation about how biology is becoming designable matter, about what it takes for an Italian discovery to become a business, and about why biotech demands timelines, capital and a mindset unlike those of any other technological innovation.